News | News By Subject | News by Disease News By Date | Search News
Get Our FREE
Industry eNewsletter
email:    
   

Ce3 Release: Clinical Operations Director Presenting At Oncology Conference


7/10/2014 9:38:10 AM

free biotech news Get the latest biotech news where you want it. Sign up for the free GenePool newsletter today!

Guilford, CT, July 10, 2014 – Ce3 Inc. a Clinical Contract Research Organization, today announced that its Director of Clinical Operations, Susan Albert, will present at the “3rd Annual Clinical Operations in Oncology Trials East Coast” conference being held at The Revere Hotel, Boston, MA.

Ms. Albert will present a session called “When Standardizing Elements of Your Clinical Trials, Don’t Forget About the eTMF”, covering topics such as:

• Common regulatory findings on the TMF
• Sponsor’s oversight and accessibility to the TMF
• TMF Reference Model
• 2014 Survey Results
• Audit readiness and standardization

Ms. Albert is scheduled to present on: Tuesday, July 15, 2014: 12 - 12:30 PM

For more information about the Conference please visit:

http://www.arena-international.com/oncologyusa/ .

About Ce3

Ce3 is a full service contract research organization focused on providing biotechnology companies with Early Phase clinical trial execution and regulatory submission services. CE3 stands for Collaborative, Experience, Efficiency & Excellence which are qualities that represent our core values and serve as the foundation for all that we do. Clients benefit from our flexibility, process efficiency, value pricing, and our collaborative relationships with state-of-the-art niche providers; a competitive edge that amplifies value in this highly regulated environment. For more information on Ce3 services, please visit www.Ce3.com and/or follow Ce3 on LinkedIn.

Help employers find you! Check out all the jobs and post your resume.


comments powered by Disqus
Ce3
 
 

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES